Patient organization
Appears in 1 story · Last updated Nov 6, 2026
Reviewing safety information with clinical experts
Nine children who received Zolgensma, a one-time gene therapy for spinal muscular atrophy, later developed tumors. In two of the three cases tested, Novartis found evidence the virus used to deliver the treatment had inserted itself into the patient's DNA.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
